$33.23
-0.28 (-0.84%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+13.41%
1Y
-6.55%
YTD
-6.18%
Open$33.50
Previous Close$33.51
Day High$34.20
Day Low$33.10
52W High$43.15
52W Low$22.96
Volume—
Avg Volume2.27M
Market Cap3.76B
P/E Ratio—
EPS$-4.15
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$32.83
Above
SMA 200
$31.34
Above
RSI (14)
52.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
26 analysts
Price Target
+105.3% upside
Current
$33.23
$33.23
Target
$68.21
$68.21
$46.84
$68.21 avg
$80.11
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.82B | 1.78B | 1.68B |
| Net Income | 202.06M | 220.26M | 147.13M |
| Profit Margin | 11.1% | 12.3% | 8.7% |
| EBITDA | 246.26M | 251.94M | 230.42M |
| Free Cash Flow | 210.43M | 219.41M | 153.78M |
| Rev Growth | +17.6% | -0.7% | +11.4% |
| Debt/Equity | 0.22 | 0.23 | 0.23 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |